Systemic Drug Delivery via the Buccal Mucosal Route

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-06-02-2001
Volume 25
Issue 6

Transmucosal routes of drug delivery offer distinct advantages over peroral administration for systemic effect. The authors review buccal drug delivery and discuss the current status of buccal permeation enhancers.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content